inpellis Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

inpellis General Information

Description

Operator of a pharmaceutical company to develop trans-dermal product candidates for treating acute and chronic pain. The company' services focus on providing trans-dermal drugs by developing and applying novel technological advances for musculoskeletal disorders and peripheral neuropathy through biophysical modulation, enabling medical researchers to find an alternative to deliver and consume FDA-approved drugs for treating chronic pain resulting from musculoskeletal disorders and peripheral neuropathy.

Contact Information

Formerly Known As
Alterix
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 30 Washington Avenue
  • Suite F
  • Haddonfield, NJ 08033
  • United States
+1 (978)
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Corporate Office
  • 30 Washington Avenue
  • Suite F
  • Haddonfield, NJ 08033
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

inpellis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-May-2016 Completed Out of Business
2. IPO 18-Mar-2016 Cancelled Clinical Trials - Phase 1
1. Seed Round 01-Sep-2015 $4.25M $4.25M Completed Startup
To view inpellis’s complete valuation and funding history, request access »

inpellis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company to develop trans-dermal product candidates for treating acute and chronic pain. The
Pharmaceuticals
Haddonfield, NJ
6 As of 2015

Vienna, Austria
 

Raritan, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

inpellis Competitors (26)

One of inpellis’s 26 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Amyndas Pharmaceuticals Accelerator/Incubator Backed Jackson, WY
Pfizer Pakistan Corporation Karachi, Pakistan
Semnur Pharmaceuticals Formerly VC-backed Palo Alto, CA
You’re viewing 5 of 26 competitors. Get the full list »

inpellis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

inpellis FAQs

  • When was inpellis founded?

    inpellis was founded in 2012.

  • Where is inpellis headquartered?

    inpellis is headquartered in Haddonfield, NJ.

  • What is the size of inpellis?

    inpellis has 6 total employees.

  • What industry is inpellis in?

    inpellis’s primary industry is Pharmaceuticals.

  • Is inpellis a private or public company?

    inpellis is a Private company.

  • What is inpellis’s current revenue?

    The current revenue for inpellis is .

  • How much funding has inpellis raised over time?

    inpellis has raised $4.25M.

  • Who are inpellis’s competitors?

    Pfizer (Vienna), Johnson&Johnson Innovative Medicine, Amyndas Pharmaceuticals, Pfizer Pakistan, and Semnur Pharmaceuticals are some of the 26 competitors of inpellis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process